Expert Speakers Include

David Berman

Head of Research and Development

Immunocore

Dolores Schendel

CEO

Medigene

Blake Aftab

Head of Preclinical and Translational Sciences

Atara Biotherapeutics Inc.

Laurence Cooper

Chief Executive Officer

Ziopharm Oncology

Steffen Walter

Chief Scientific Officer

Immatics US

Gang Zeng

Chief Executive Officer

T-Cure Biosciences Inc.

Elisa Kieback

CEO

T-knife

Hans-Peter Gerber

Chief Scientific Officer

3T Biosciences

Robert Hofmeister

Chief Scientific Officer

TCR2

Paul Lammers

Chief Executive Officer

Triumvira

Cheng Liu

Chief Executive Officer

Eureka Therapeutics

Gavin MacBeath

Chief Scientific Officer

TScan Therapeutics

Chia Chen-Rogers

Senior Director, Oncology Cell Therapy New Products

GSK

Mark Omobono

Senior Associate Scientist

Bluebird Bio

Hugh Salter

Chief Scentific Officer

Anocca AB

David Scheinberg

Chairman, Molecular Pharmacology

Memorial Sloan Kettering Cancer Center

Bob Valamehr

Chief Development Officer

Fate Therapeutics

Erika Von Euw

Associate Director of Translational Research

T-Cure Biosciences Inc

Michael Magee

Senior Scientist

bluebird bio

Anthony Purcell

Professor Biochemistry & Molecular Biology

Monash Biomedicine Discovery Institute